Depression Treatment Utilization Low in Symptomatic Patients
Treatment rates for patients with major depressive disorder with an elevated PHQ-9 score were characterized in this study.
Treatment rates for patients with major depressive disorder with an elevated PHQ-9 score were characterized in this study.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Investigators conducted a comprehensive literature search to identify key characteristics that best differentiate between bipolar I disorder and major depressive disorder.
Researchers sought to evaluate the prevalence of pre-existing conditions for adverse events and potential drug-drug interactions related to selected atypical antipsychotics and other non-antidepressant agents among adults with treatment-resistant depression.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
During the COVID-19 outbreak in Hubei province in China, 22.6% of children in home confinement reported depressive symptoms.
PPD requiring hospitalization higher among women undergoing general anesthesia for cesarean delivery.
Times between mood episodes longer for those in family-focused therapy vs enhanced usual care.
Results published in JAMA Network Open suggest that physicians with positive screening for depressive symptoms were at higher risk for making medical errors.